Glucagon-like peptide-1(7-36) amide enhances insulin-stimulated glucose uptake and decreases intracellular cAMP content in isolated rat adipocytes

被引:37
作者
Miki, H
Namba, M
Nishimura, T
Mineo, I
Matsumura, T
Miyagawa, J
Nakajima, H
Kuwajima, M
Hanafusa, T
Matsuzawa, Y
机构
[1] OTEMAE HOSP,OSAKA 540,JAPAN
[2] UNIV TOKUSHIMA,SCH MED,DEPT LAB MED,TOKUSHIMA 770,JAPAN
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 1996年 / 1312卷 / 02期
关键词
glucagon-like peptide-1(7-36)amide; glucose uptake; cAMP; adipocyte; (rat);
D O I
10.1016/0167-4889(96)00032-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated the effect of GLPs on glucose uptake in isolated rat adipocytes, GLP-1(7-36)amide significantly enhanced glucose uptake in the presence of 1 nM insulin. GLP-1(7-36)amide at 15 nM increased glucose uptake maximally by 56.4% as compared with 1 nM insulin alone (P < 0.01), In contrast, with less than 1 nM insulin or without insulin GLP-1(7-36)amide showed no effect on glucose uptake. Full-sequence GLP-1(1-37) at 15 nM in the presence of 1 nM insulin increased glucose uptake by 24.6% as compared with 1 nM insulin alone (P < 0.05). GLP-2 showed no effect on glucose uptake. Further, we examined the effect of GLP-1(7-36)amide on cAMP content in isolated rat adipocytes, Insulin at 1 nM caused a significant decrease of cAMP content, The combination of 15 nM GLP-1(7-36)amide and 1 nM insulin caused a further reduction of cAMP content. These data indicate that GLP-1(7-36)amide possesses augmentative effects on insulin action in isolated rat adipocytes. Furthermore, it is suggested that the stimulatory effect of GLP-1(7-36)amide occurs through the reduction of intracellular cAMP content.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 24 条
[1]  
BEGUM N, 1993, J BIOL CHEM, V268, P3352
[2]  
DUPRE J, 1991, ENDOCRINE PANCREAS, P253
[3]  
EBERT R, 1987, Diabetes Metabolism Reviews, V3, P1
[4]   FAILURE OF GLP-1(7-36)AMIDE TO AFFECT GLYCOGENESIS IN RAT SKELETAL-MUSCLE [J].
FURNSINN, C ;
EBNER, K ;
WALDHAUSL, W .
DIABETOLOGIA, 1995, 38 (07) :864-867
[5]  
GLIEMANN J, 1985, METHODS DIABET RES, P106
[6]   ANTIDIABETOGENIC EFFECT OF GLUCAGON-LIKE PEPTIDE-1 (7-36)AMIDE IN NORMAL SUBJECTS AND PATIENTS WITH DIABETES-MELLITUS [J].
GUTNIAK, M ;
ORSKOV, C ;
HOLST, JJ ;
AHREN, B ;
EFENDIC, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (20) :1316-1322
[7]   TRUNCATED GLUCAGONLIKE PEPTIDE-I, AN INSULIN-RELEASING HORMONE FROM THE DISTAL GUT [J].
HOLST, JJ ;
ORSKOV, C ;
NIELSEN, OV ;
SCHWARTZ, TW .
FEBS LETTERS, 1987, 211 (02) :169-174
[8]   ISOPROTERENOL STIMULATES PHOSPHORYLATION OF THE INSULIN-REGULATABLE GLUCOSE TRANSPORTER IN RAT ADIPOCYTES [J].
JAMES, DE ;
HIKEN, J ;
LAWRENCE, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (21) :8368-8372
[9]   GLUCAGONOSTATIC AND INSULINOTROPIC ACTION OF GLUCAGON-LIKE PEPTIDE I-(7-36)-AMIDE [J].
KOMATSU, R ;
MATSUYAMA, T ;
NAMBA, M ;
WATANABE, N ;
ITOH, H ;
KONO, N ;
TARUI, S .
DIABETES, 1989, 38 (07) :902-905
[10]  
KREYMANN B, 1987, LANCET, V2, P1300